http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29405206

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, U.S. Gov't, P.H.S.
endingPage 8
issn 1078-0432
issueIdentifier 10
pageRange 3263-8
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 3263
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_290248e41ee2266e14d8f34ceaae2846
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_abba1f324dd4eda5c36134fe4618ec51
bibliographicCitation Blackstock AW, Lightfoot H, Case LD, Tepper JE, Mukherji SK, Mitchell BS, Swarts SG, Hess SM. Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. Clin Cancer Res. 2001 Oct;7(10):3263–8. PMID: 11595723.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c16c8a0a37e2cf24b5befc575055f273
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d81a200d8483963aa2066e70da219cc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08b58277e22d3aecff9fba0567437160
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48a7f8f9ba19b1fc2159faa43f2af6a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2047ae704ae1ec312b18ed3cd4a2b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da6c0285eaf6c791a1342499527d19f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1ec4831997dffc2ff3c5f10b3685a6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5626d92d481d4373b3a544e5f20daed
date 200110
identifier https://pubmed.ncbi.nlm.nih.gov/11595723
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response
discusses http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0008618
http://id.nlm.nih.gov/mesh/M000754277
http://id.nlm.nih.gov/mesh/M0005577
http://id.nlm.nih.gov/mesh/M0005998
http://id.nlm.nih.gov/mesh/M0153651
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D003841Q000031
http://id.nlm.nih.gov/mesh/D003570Q000031
http://id.nlm.nih.gov/mesh/D009374Q000378
http://id.nlm.nih.gov/mesh/D003842Q000235
http://id.nlm.nih.gov/mesh/D003841Q000493
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D003841Q000378
http://id.nlm.nih.gov/mesh/D018014
http://id.nlm.nih.gov/mesh/D003842Q000378
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D000093542
http://id.nlm.nih.gov/mesh/D002851
http://id.nlm.nih.gov/mesh/D009374Q000188
http://id.nlm.nih.gov/mesh/D005461
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D019073
http://id.nlm.nih.gov/mesh/D002455Q000187
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D015971
http://id.nlm.nih.gov/mesh/D009374Q000235
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D009682Q000379
http://id.nlm.nih.gov/mesh/D003570Q000378
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_15916aaa573d072780b1386107155838

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136044168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247909998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 67.